期刊文献+

ID1蛋白在胃癌组织中的表达及临床意义 被引量:7

Expression and clinical significance of ID1 in gastric cancer
暂未订购
导出
摘要 目的分析人胃癌组织中分化抑制因子1(ID1)的表达与临床病理参数之间的关系,初步探讨ID1在胃癌发生、发展及患者预后评估中的作用。方法免疫组织化学EliVision法检测91例胃癌组织、30例正常胃黏膜和35例不典型增生胃黏膜组织中ID1蛋白的表达,分析ID1蛋白表达与胃癌的分化程度、浸润深度、临床TNM分期和淋巴结转移的关系,绘制生存曲线,Log-rank法单因素分析肿瘤临床病理学特征和ID1蛋白的表达与患者预后的关系。结果免疫组织化学染色结果显示:胃癌组织中ID1蛋白的表达阳性率为63.7%(58/91),显著高于正常胃黏膜组织(10.0%)和不典型增生胃黏膜组织(42.9%),差异均有统计学意义(P<0.05)。统计学分析结果显示,胃癌组织中ID1蛋白的表达与肿瘤的分化程度、浸润深度、临床TNM分期和淋巴结转移有关(P<0.05)。Log-rank法单因素分析结果显示,肿瘤浸润深度与淋巴结转移与胃癌患者的预后有关(P<0.05),而与患者年龄、性别及肿瘤直径、大体类型、分化程度、Lauren分型和ID1蛋白的表达等无关(P>0.05)。结论 ID1在胃癌组织中表达异常,可能与胃癌的发生和发展有关,有望为胃癌治疗提供新的治疗靶点,但并非是胃癌患者预后的评估指标。 Objective To investigate the relationship between expression of inhibitor of DNA binding/differentiation 1 (ID1) and clinicopathologieal parameters, and explore the role of ID1 in the development and prognosis prediction of gastric cancer. Methods The expression of ID1 protein in 91 samples of gastric cancer tissues, 30 samples of normal gastric tissues and 35 samples of atypical hyperplasia gastric tissues was examined by immunohistoehemical EliVision method. The relationship between expression of ID1 protein and differentiation, invasion, TNM stage and lymph node metastasis of gastric cancer was analysed, the survival curves were drawn, and the correlation of elinieopathological parameters and expression of ID1 protein with prognosis of patients with gastric cancer was explored with Log-rank univariate analysis. Results Immunohistochemieal staining revealed that the positive rate of expression of ID1 protein in gastric cancer tissues was 63.7% (58/91), which was significantly higher than those in normal gastric tissues (10.0%) and atypical hyperplasia gastric tissues (42.9%) ( P 〈 0.05). Statistical analysis indicated that the expression of ID1 protein was related to the differentiation, invasion, TNM stage and lymph node metastasis of gastric cancer ( P 〈 0.05) . Log-rank univariate analysis demonstrated that the invasion and lymph node metastasis of gastric cancer were related to the prognosis of patients ( P 〈 0.05), while the prognosis of patients was not related to the age, sex, diameter of tumor, gross type, differentiation, Lauren classification and expression of ID1 protein ( P 〉 0.05). Conclusion The expression of ID1 in gastric cancer is abnormal, which may be associated with the occurrence and development of gastric cancer. ID1 may be the new therapeutic targets for the treatment of gastric cancer, while it may not be the prognostic factors of patients with gastric cancer.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期298-302,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 安徽高校省级自然科学研究项目(KJ2007B277)~~
关键词 胃肿瘤 免疫组织化学 ID1 stomach neoplasm immunohistochemistry, ID1
  • 相关文献

参考文献19

  • 1Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epide- miology, pathology and treatment [ J ]. Ann Oncol, 2003, 14 ( 2 ) : 31 -36.
  • 2杨海平,张才全.胃癌基因治疗的研究进展[J].现代肿瘤医学,2008,16(6):1058-1061. 被引量:11
  • 3Schmidt M, Asirvatham A J, Chaudhary J. Inhibitor of differentiation 1 ( Idl ) promotes cell survival and proliferation of prostate epithelial cells[J]. CellMolBiolLett, 2010, 15(2): 272 -295.
  • 4Yu XL, Xu XH, Han BJ, et al. Inhibitor of DNA Binding-I nverex- pression in prostate cancer: relevance to tumor differentiation [J].Pathol Oncol Res, 2009, 15( 1 ) : 91 -96.
  • 5Ciarrocchi A, Piano S, Valcavi R, et al. Inhibitor of DNA binding-I induces mesenehymal features and promotes invasiveness in thyroid tumour cells[J]. Cur J Cancer, 2011, 47(6): 934 -945.
  • 6Mellick AS, Plummer PN, Nolan DJ, et al. Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth[J]. Cancer Res, 2010, 70(18) : 7273 -7282.
  • 7Yu XL, Jing T, Shang FF, et al. Down regulation of Idl by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro [ J ]. Cur J Cancer Prey, 2011, 20(1): 9- 17.
  • 8许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 9Benezra R, Davis RL, Loekshon D, et al. The protein Id: a nega- tive regulator of Helix-Loop-Helix DNA binding proteins [ J ]. Cell, 1990, 61(1) : 49 -59.
  • 10Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence[J]. Oncogene, 2001, 20(58): 8317-8325.

二级参考文献8

共引文献1388

同被引文献44

  • 1沈志祥,朱雄增.恶性淋巴瘤[M].北京:人民出版社,2011:701.
  • 2葛均波,钟南山.内科学[M].8版.北京:人民卫生出版社,2013:21.
  • 3Chen D,Forootan SS,Gosney JR.Increased expression of Idl and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung canc-er[J].Genes Cancer,2014,5(56):212-225.
  • 4Gumireddy K,Li A,Kossenkov AV.IDl promotes breast cancer metastasis by S100A9 regulation[J].Mol Cancer Res,2014,12(9):1334-1343.
  • 5Yang G,Zhang Y,Xiong J.Downregulation of Idl by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway[J].Mol Med Report,2012,5:1075-1079.
  • 6Munipalle PC,Viswanath YK,Davis PA,et al.Prognostic value of hypoxia inducible factor la in esophageal squamous cell carcinoma[J].Dis Esophagus,2011,24:177-181.
  • 7Yang G,Zhang Y,Xiong J. Downregulation of Id-1 by small inter- fering RNA in gastric cancer inhibits cell growth via the Akt path- way[J]. Mol Med Report,2012,5(4) :1075 -1079.
  • 8Bhattancharya R,Kowalski J,Larson AR,et al. Id-1 promotes tumor cell migration in non-small cell lung cancers [ J ]. J Oncol, 2010, 2010:856105.
  • 9Chen Z,Liu S,Sumida T,et al. Silencing Id-1 with RNA interfer- ence inhibits adenoid cystic carcinoma in mice [ J ]. J Surg Res, 2011.169( 1 ) :57 -56.
  • 10Rothschild SI, Kappeler A, Ratschiller D, et al. The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non- small cell lung cancer[ J ]. Lung Cancer,2011,71 ( 5 ) :306 - 311.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部